4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-20-034062
CIK 0001539029other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:43 PM ET
Size
5.8 KB
Accession
0001209191-20-034062
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-06-01$1.88/sh−14,992$28,185→ 220,827 total
Footnotes (3)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 1,963 shares and 5,000 shares acquired under the Issuer's employee stock purchase plan on June 29, 2018 and December 31, 2019, respectively.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:43 PM ET
- Size
- 5.8 KB